A leading company in rare disease therapeutics is seeking novel treatments for rare genetic skeletal diseases and genetically defined subsets of common skeletal diseases. They are also interested in delivery techniques to target bone tissues, ideally coupled with novel therapeutics.
Approaches of Interest:
Combination of a novel therapeutics approach with a bone-targeting mechanism will be a reviewed as a high priority, but separate approaches in either area of interest.
Clinical Indications of Interest: Apert Syndrome, Autosomal Dominant Osteopetrosis, Ehlers-Danlos Syndrome, Hereditary Multiple Exostoses/Osteochondromas, Hypophosphatasia, Osteogenesis Imperfecta, Pseudoachondroplasia, Spondyloepiphyseal Dysplasia Congenita, Stickler Syndrome, and X-Linked Hypophosphatemic Rickets. Genetic subsets of more common disease (E.g. osteoporosis, osteoarthritis).
Out of Scope:
Developmental Stages of Interest:
Submission Information & Opportunity for Collaboration
Submission of 200–300-word briefs is encouraged, along with any supplementary information e.g. relevant publications, patents or slide decks. The team encourages including the proposed next steps in developing the research towards commercialization. In submitting to this campaign, you confirm that your submission contains only non-confidential information.
Our client is looking to establish long-standing partnerships in the field of rare skeletal disease. The most appropriate outcomes for submissions to this campaign will be decided on a case-by-case basis. Example outcomes include funded research collaborations and agreements or licencing of assets.
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.